We’re a team of doctors, engineers, and technologists — optimistic about the science of cryopreservation
Engineering new solutions to improve cryopreservation practices.
Tomorrow.bio is dedicated to advancing the future of cryopreservation wordwide, with cutting-edge technologies.
Our international team merges top medical expertise with a shared passion for cryonics.
Since July 2024, we’ve been bringing our German and Swiss quality standards to the US. If you’re traveling, we have you covered.
At Tomorrow.bio, transparency is at the heart of our operations and our team is committed to ensuring that every aspect of our cryopreservation is open and accessible.
Tomorrow.bio was founded to further biostasis science and provide high-quality cryopreservation in the heart of Europe. 
Get to know more about our mission and our team.
Our purpose
Why was Tomorrow.bio founded?
Tomorrow.bio's co-founder, Dr. Emil Kendziorra, started his work in the field of cancer research with the goal of contributing to life extension science. After realizing that longevity science was not advancing fast enough, Emil switched his focus to biostasis.
Vision
To build a world where people can choose how long they want to live — independent of where they are, who they are, and their financial resources.
Mission
To spread awareness and inform people openly about the option of cryopreservation. To offer a high-quality service. And to conduct and fund research to further the field of cryonics.
Research goals
Engineering solutions to improve cryopreservation cases that might happen tomorrow and to conduct applied and translational research to fundamentally improve the field in the long term.
Company timeline
2020
Jan 2020 Founded
Mar 2020 First members
Jun 2020 Tomorrow.bio is operational with the #1 perfusion system
Sep 2020 EBF was founded
Nov 2020 #1 Ambulance operational
2021
Jan 2021 Website 2.0 and marketing started
Feb 2021 First 160 members
Oct 2021 #1 Biostasis Conference in Zürich
2022
Mar 2022 EBF Facility was completed
Jun 2022 Received the first Dewar, fully operational
Dec 2022 Reached 250 Members
2023
Mar 2023 First cryopreserved patient
Aug 2023 First cryopreserved pet
Oct 2023 Second ambulance acquired
2024
Apr 2024 First complete brain cryopreservation
Jun 2024 Reached 600 members
Jul 2024 We launched in the US
Aug 2024 3rd ambulance in Switzerland
Company timeline
Step 1
Sign-up
Patients wishing to be cryopreserved sign up for a membership with Tomorrow.bio. We help them get the necessary paperwork in order, ensure there’s insurance or funds in place to pay for the cryopreservation procedure and stay ready to cryopreserve them whenever death occurs. For people signing up at the last minute, we have special rates.
Step 2
Dispatch
Most deaths can be predicted by medical conditions and circumstances. When there are signs that a patient might be dying, we dispatch one of our ambulances with a biostasis response team. They usually arrive before death occurs, allowing us to start the stabilization process as soon as the patient is legally pronounced dead.
Step 3
Stabilization
We cool the patient down as quickly as possible using ice and water. Then we initiate cardiopulmonary support (CPS) and infuse them with neuroprotective and anti-clotting medication. This stabilizes the patient, slows down the degradation process, and prepares the patient for cryoprotection.
Step 4
Cryoprotection
Our ambulances are fully equipped to perform field cryopreservation, allowing us to get right to work: During our cryoprotection procedure, we will slowly replace the patient’s blood with cryoprotectant and cool them down further. The cryoprotectant protects the body during the cooldown.
Step 5
Transport
We transport the patient to our storage facility in Switzerland.
Step 6
Cool-down
At the facility, the cryoprotected patients are placed in a cool-down chamber. As quickly as possible, we cool them to -120°C, where they will undergo a process called vitrification, which is a glass-like transition of the body. Following this process, we slow the cool-down to about 1°C per hour to avoid thermal stress. Cool-down finishes when the patient has reached -196°C.
Step 7
Storage
Patients are placed in a pod, which is then placed in a cryogenic dewar filled with liquid nitrogen. Here they are stored indefinitely, with no electricity required. The liquid nitrogen is regularly refilled by the on-site team or an automated system.
Basic info
Key facts about Tomorrow.bio
Founders
Tomorrow.bio was founded in 2020 by Dr. Emil Kendziorra and Fernando Azevedo Pinheiro. Emil, a trained medical doctor, spent years as a cancer researcher and entrepreneur before establishing Tomorrow. Fernando, an industrial and civil engineer with an MBA, has extensive experience as a tech executive and entrepreneur.
Location
Tomorrow.bio's office is located in central Berlin. You are welcome to come by and visit if you want to meet the team or see one of our medical standby ambulances. In addition to a Berlin standby team we also standby teams all over Europe.
Storage
Our patients are stored in the underground part of the European Biostasis Foundation's (EBF) facility in Switzerland. EBF is a non-profit organization that works together with Tomorrow.bio to provide a high quality and secure cryopreservation service.
We’ve created a unique structure based on a German company and two foundations in Switzerland to guarantee the long-term viability of our operation and to secure the needs of our patients.